- (a) In this subtitle the following words have the meanings indicated.
- (b) “Co-prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.
- (c) “Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.
Added by Acts 2017, c. 571, § 1, eff. June 1, 2017; Acts 2017, c. 572, § 1, eff. June 1, 2017.